Petmed Express Inc PETS
We take great care to ensure that the data presented and summarized in this overview for PETMED EXPRESS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PETS
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny1.3MShares$6.13 Million0.01% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA1.09MShares$5.13 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$5.08 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA606KShares$2.85 Million0.01% of portfolio
-
Black Rock Inc. New York, NY556KShares$2.61 Million0.0% of portfolio
-
Oaktop Capital Management Ii, L.P. Chatham, NJ436KShares$2.05 Million0.17% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA406KShares$1.91 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY321KShares$1.51 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT264KShares$1.24 Million0.0% of portfolio
-
Metavasi Capital LP Larchmont, NY229KShares$1.08 Million0.41% of portfolio
Latest Institutional Activity in PETS
Top Purchases
Top Sells
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Insider Transactions at PETS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 27
2024
|
Robyn M. D'Elia Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
Sep 09
2024
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,500
+0.6%
|
$37,500
$3.34 P/Share
|
Aug 15
2024
|
Jacqueline Paula Smith |
SELL
Open market or private sale
|
Direct |
601
-2.9%
|
$1,803
$3.19 P/Share
|
Aug 08
2024
|
Gian Fulgoni Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+5.68%
|
-
|
Aug 08
2024
|
Diana G Purcel Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+23.53%
|
-
|
Aug 08
2024
|
Justin L. Mennen Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+45.81%
|
-
|
Aug 08
2024
|
Leah Solivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+47.04%
|
-
|
Aug 08
2024
|
Leslie C.G. Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+12.0%
|
-
|
Jul 01
2024
|
Leah Solivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
943
+50.0%
|
-
|
Jun 03
2024
|
Justin L. Mennen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+50.0%
|
-
|
May 31
2024
|
Christine Chambers CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,342
-38.82%
|
-
|
May 16
2024
|
Christine Chambers CFO |
BUY
Grant, award, or other acquisition
|
Direct |
74,850
+41.28%
|
-
|
Apr 29
2024
|
Mathew N Hulett |
SELL
Sale (or disposition) back to the issuer
|
Direct |
510,000
-83.08%
|
-
|
Apr 29
2024
|
Sandra Yvette Campos CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
483,092
+49.61%
|
-
|
Dec 11
2023
|
Mark Bradley Moseley Jr |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+25.0%
|
$98,000
$7.14 P/Share
|
Nov 09
2023
|
Gian Fulgoni Director |
BUY
Open market or private purchase
|
Direct |
41,000
+27.24%
|
$287,000
$7.34 P/Share
|
Nov 03
2023
|
Mathew N Hulett |
BUY
Open market or private purchase
|
Direct |
13,850
+2.21%
|
$96,950
$7.26 P/Share
|
Nov 03
2023
|
Christine Chambers CFO |
BUY
Open market or private purchase
|
Direct |
6,888
+25.72%
|
$48,216
$7.26 P/Share
|
Aug 14
2023
|
Jacqueline Paula Smith |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+50.0%
|
-
|
Aug 03
2023
|
Sandra Yvette Campos CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 862K shares |
---|---|
Open market or private purchase | 12.5K shares |
Sale (or disposition) back to the issuer | 551K shares |
---|---|
Open market or private sale | 601 shares |